IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Vhcp Management II, LLC

Q1 2018 Holdings

Filed 2018-05-14 | 17 holdings | $77.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Ascendis Pharma A/S(ASND)COM04351P101$38.3M586,19549.7%
Argenx(ARGX)COM04016X101$27.9M346,79236.1%
BioCryst Pharmaceuticals Inc(BCRX)COM09058V103$10.6M2,220,97113.7%
AveXis IncCOM05366U100$128.0K1,035,6570.2%
Endocyte IncCOM29269A102$39.1K4,300,0000.1%
Biohaven Pharmaceuticals(BHVN)COMG11196105$35.8K1,390,3910.0%
Obseva SACOMH5861P103$28.9K2,143,8430.0%
AnaptysBio(ANAB)COM032724106$18.8K180,9500.0%
DBV TechnologiesCOMF2927N109$18.1K616,2170.0%
ZogenixCOM98978L204$14.5K362,0100.0%
Catalyst BiosciencesCOM14888D109$14.3K553,6290.0%
Menlo TherapeuticsCOM586858102$12.8K340,0000.0%
Bellerophon Therapeutics(BLPHEUR)COM078771102$8.6K4,149,3780.0%
Momenta Pharmaceuticals(MNTA)COM60877T100$7.7K425,0000.0%
Spero Therapeutics Inc(SPRO)COM84833T103$6.9K485,6150.0%
Ra PharmaceuticalsCOM74933V108$2.9K544,6120.0%
Savara Inc(SVRA)COM805111101$1.1K119,8400.0%